LOC100043326 inhibitors such as Staurosporine and Genistein target broad kinase activities and may affect LOC100043326 if it is regulated by phosphorylation. Compounds like Cycloheximide and MG-132 address the protein synthesis and degradation machinery, which could alter the levels of LOC100043326 within the cell. Epigenetic modulators like 5-Azacytidine and Trichostatin A could influence the expression of LOC100043326 by altering DNA methylation and histone acetylation, respectively.
Moreover, small molecules such as LY294002 and PD98059 that inhibit specific kinases like PI3K and MEK could impact the activity of LOC100043326 if it is a part of these signaling pathways. Rapamycin and Bortezomib, by modulating mTOR signaling and proteasomal degradation, could also affect the protein's function or stability. Geldanamycin, an inhibitor of Hsp90, may influence the proper folding and stability of LOC100043326 if it is a client protein of this chaperone. Lastly, SB431542 could alter the function of LOC100043326 by changing the TGF-beta signaling dynamics.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can modulate cell signaling pathways, potentially affecting LOC100043326 if it plays a role in signal transduction. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis by interfering with the translocation step in protein synthesis, possibly affecting LOC100043326 synthesis. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of proteins, potentially influencing the turnover of LOC100043326 if it is regulated by proteasomal degradation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A tyrosine kinase inhibitor that can alter phosphorylation states of proteins, potentially affecting LOC100043326 if it relies on tyrosine phosphorylation for its activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to demethylation and activation of genes, possibly influencing LOC100043326 expression if epigenetically regulated. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can change chromatin structure and gene expression, potentially affecting LOC100043326 if it is regulated by histone acetylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can disrupt downstream signaling pathways, potentially affecting LOC100043326 if it is involved in the PI3K/Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that impedes the MAPK/ERK pathway, potentially affecting LOC100043326 if it is part of this signaling cascade. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can disrupt cell growth and proliferation signaling, potentially affecting LOC100043326 if it is involved in mTOR signaling. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect protein degradation pathways, potentially influencing LOC100043326 stability or function. | ||||||